Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ling-Yun Mou"'
Autor:
Xiao-Wei Zhang, Jing-Yi Li, Lin Li, Wen-Qian Hu, Yan Tao, Wen-Yan Gao, Zi-Nuo Ye, Hao-Yuan Jia, Jia-Nan Wang, Xiao-Kang Miao, Wen-Le Yang, Rui Wang, Ling-Yun Mou
Publikováno v:
Cell Death and Disease, Vol 14, Iss 6, Pp 1-14 (2023)
Abstract The widespread application of antiandrogen therapies has aroused a significant increase in the incidence of NEPC, a lethal form of the disease lacking efficient clinical treatments. Here we identified a cell surface receptor neurokinin-1 (NK
Externí odkaz:
https://doaj.org/article/453118b6c7714aab839ca9159237370e
Autor:
Xiao-Wei Zhang, Lin Li, Wen-Qian Hu, Ming-Ning Hu, Yan Tao, Hui Hu, Xiao-Kang Miao, Wen-Le Yang, Qiong Zhu, Ling-Yun Mou
Publikováno v:
Cell Death and Disease, Vol 13, Iss 1, Pp 1-15 (2022)
Abstract Despite the great advances in target therapy, lung cancer remains the top cause of cancer-related death worldwide. G protein-coupled receptor neurokinin-1 (NK1R) is shown to play multiple roles in various cancers; however, the pathological r
Externí odkaz:
https://doaj.org/article/8a17f837c34640d2b752add9d958006d
Autor:
Changjun Yu, Ruiyao E., Xiao‐Wei Zhang, Wen‐Qian Hu, Guangjun Bao, Yiping Li, Yuyang Liu, Zeyuan He, Jingyue Li, Wen Ma, Ling‐Yun Mou, Rui Wang, Wangsheng Sun
Publikováno v:
ChemMedChem. 18
Innovations in synthetic chemistry have a profound impact on the drug discovery process, and will always be a necessary driver of drug development. As a result, it is of significance to develop novel simple and effective synthetic installation of med
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::763b9971e41d5d3ee78e0a0b74c520a8
https://doi.org/10.1002/cmdc.202200651
https://doi.org/10.1002/cmdc.202200651
Autor:
Yi-Xin, Zhang, Xiao-Fang, Li, Guo-Qiang, Yuan, Hui, Hu, Xiao-Yun, Song, Jing-Yi, Li, Xiao-Kang, Miao, Tian-Xiong, Zhou, Wen-Le, Yang, Xiao-Wei, Zhang, Ling-Yun, Mou, Rui, Wang
Publikováno v:
The Journal of biological chemistry. 292(21)
Glioblastoma is the most common malignant brain tumor and has a poor prognosis. Tachykinin receptor neurokinin-1 (NK1R) is a promising target in glioblastoma therapy because of its overexpression in human glioblastoma. NK1R agonists promote glioblast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::52204f61189e5e59674d5775d2621b4f
https://pubmed.ncbi.nlm.nih.gov/28341744
https://pubmed.ncbi.nlm.nih.gov/28341744
Autor:
Yi-Xin Zhang1, Xiao-Fang Li1, Guo-Qiang Yuan2, Hui Hu1, Xiao-Yun Song1, Jing-Yi Li1, Xiao-Kang Miao1, Tian-Xiong Zhou1, Wen-Le Yang1, Xiao-Wei Zhang1, Ling-Yun Mou1 muly@lzu.edu.cn, Rui Wang1 wangrui@lzu.edu.cn
Publikováno v:
Journal of Biological Chemistry. 5/26/2017, Vol. 292 Issue 21, p8933-8947. 15p.